Cambridge, MA, United States of America

Jacob Witten

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Massachusetts Institute of Technology. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jacob Witten: Innovator in Lipid Delivery Systems

Introduction

Jacob Witten is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of lipid delivery systems, particularly in the context of therapeutic applications. His work focuses on the development of innovative compounds that can enhance the delivery of genetic materials for medical treatments.

Latest Patents

Jacob Witten holds a patent for "Ionizable lipids and compositions and uses thereof." This patent includes compounds that are useful for the delivery of polynucleotides, such as mRNA, aimed at treating and preventing various diseases and conditions. These conditions include genetic diseases, proliferative diseases, hematological diseases, neurological diseases, liver diseases, and more. The compounds described in the patent are versatile and can be utilized in various pharmaceutical applications.

Career Highlights

Jacob Witten is affiliated with the Massachusetts Institute of Technology, where he conducts research and development in the field of lipid-based drug delivery systems. His innovative approach has led to advancements in how genetic materials can be effectively delivered to target cells, which is crucial for the treatment of numerous health conditions.

Collaborations

Jacob has collaborated with notable colleagues, including Daniel Griffith Anderson and Luke Hyunsik Rhym. These collaborations have further enriched his research and contributed to the development of effective lipid formulations.

Conclusion

Jacob Witten's work in the field of lipid delivery systems represents a significant advancement in medical technology. His innovative patents and collaborations highlight his commitment to improving therapeutic strategies for various diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…